OK Biotech Balance Sheet Health
Financial Health criteria checks 4/6
OK Biotech has a total shareholder equity of NT$2.4B and total debt of NT$326.6M, which brings its debt-to-equity ratio to 13.6%. Its total assets and total liabilities are NT$3.1B and NT$672.3M respectively.
Key information
13.6%
Debt to equity ratio
NT$326.59m
Debt
| Interest coverage ratio | n/a |
| Cash | NT$365.34m |
| Equity | NT$2.40b |
| Total liabilities | NT$672.26m |
| Total assets | NT$3.07b |
Recent financial health updates
OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet
Mar 17
Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly
Dec 08
Recent updates
OK Biotech Co., Ltd. (TPE:4155) Investors Should Think About This Before Buying It For Its Dividend
Apr 26Calculating The Fair Value Of OK Biotech Co., Ltd. (TPE:4155)
Apr 04OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet
Mar 17Has OK Biotech (TPE:4155) Got What It Takes To Become A Multi-Bagger?
Mar 01Is OK Biotech Co., Ltd.'s (TPE:4155) Recent Price Movement Underpinned By Its Weak Fundamentals?
Feb 15A Look At OK Biotech's (TPE:4155) Share Price Returns
Jan 31We Wouldn't Rely On OK Biotech's (TPE:4155) Statutory Earnings As A Guide
Jan 17Consider This Before Buying OK Biotech Co., Ltd. (TPE:4155) For The 5.4% Dividend
Jan 03Estimating The Intrinsic Value Of OK Biotech Co., Ltd. (TPE:4155)
Dec 21Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly
Dec 08Should You Be Impressed By OK Biotech's (TPE:4155) Returns on Capital?
Nov 23Financial Position Analysis
Short Term Liabilities: 4155's short term assets (NT$1.3B) exceed its short term liabilities (NT$578.1M).
Long Term Liabilities: 4155's short term assets (NT$1.3B) exceed its long term liabilities (NT$94.1M).
Debt to Equity History and Analysis
Debt Level: 4155 has more cash than its total debt.
Reducing Debt: 4155's debt to equity ratio has reduced from 21.8% to 13.6% over the past 5 years.
Debt Coverage: 4155's debt is not well covered by operating cash flow (0.9%).
Interest Coverage: Insufficient data to determine if 4155's interest payments on its debt are well covered by EBIT.